Package 0115-3511-02

{"route": ["ORAL"], "spl_id": "3d2e45fb-a83b-4e76-b1cd-9caf2b00a804", "openfda": {"upc": ["0301153511017"], "unii": ["KVI301NA53"], "rxcui": ["903857"], "spl_set_id": ["0f56facf-1f0a-4ba5-876d-757b114dfa45"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0115-3511-01)", "package_ndc": "0115-3511-01", "marketing_start_date": "20030424"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (0115-3511-02)", "package_ndc": "0115-3511-02", "marketing_start_date": "20030424"}], "brand_name": "Pyridostigmine Bromide", "product_id": "0115-3511_3d2e45fb-a83b-4e76-b1cd-9caf2b00a804", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0115-3511", "generic_name": "PYRIDOSTIGMINE BROMIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/1"}], "application_number": "ANDA040502", "marketing_category": "ANDA", "marketing_start_date": "20030424", "listing_expiration_date": "20261231"}